EDITORIAL
Published on 26 Sep 2024
Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer
doi 10.3389/fimmu.2024.1487952
- 334 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Developing next-generation therapeutics to defeat mutation-driven cancer
Developing next-generation therapeutics to defeat mutation-driven cancer
8,278
Total downloads
23k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 10 Jan 2024
Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study
doi 10.3389/fimmu.2023.1203459
- 2,581 views
MINI REVIEW
Published on 01 Dec 2023
A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer
doi 10.3389/fonc.2023.1252652
- 9,242 views
- 4 citations
MINI REVIEW
Published on 22 Aug 2023
Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy
doi 10.3389/fimmu.2023.1258388
- 4,956 views
- 8 citations
MINI REVIEW
Published on 06 Jul 2023
The potential of activator protein 1 (AP-1) in cancer targeted therapy
doi 10.3389/fimmu.2023.1224892
- 8,506 views
- 22 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 23kTopic views
- 15kArticle views
- 8,278Article downloads